Ulrike Schumacher

ORCID: 0000-0002-4546-8497 · 7 papers in corpus · active 2008-2015

Study types

  • article 6
  • other 1

Condition tags

  • endometriosis 5
  • dysmenorrhea 1
  • mesh:D004715 1
  • mesh:D017699 1
article 2015
Effectiveness, tolerability and acceptance of a low-dosed estradiol/dienogest formulation (Lafamme 1 mg/2 mg) for the treatment of menopausal complaints: a non-interventional observational study over 6 cycles of 28 days
·doi:10.3109/09513590.2015.1024220

BACKGROUND: Concern and controversy characterize nowadays the use of hormone therapy for management of patients with menopausal complaints. This observational non-interventional study examined the use of a marketed oral formulation containi…

other 2015
Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program
International journal of women's health ·doi:10.2147/IJWH.S77202

BACKGROUND: In four randomized, controlled, European trials, dienogest 2 mg once daily demonstrated significant efficacy for lesion reduction and reduction in pain intensity in endometriosis. We describe a pooled analysis of the safety and …

article 2013
Open Access

Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials

article 2012
How can we measure endometriosis-associated pelvic pain?
·doi:10.5301/je.2012.9725

Purpose The aim of our work was to explore which of the most commonly used pain scales is best suited to assess treatment success in endometriosis therapy and, therefore, qualifies best to be used as primary endpoint for clinical studies in…

article 2010
Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials
Health and quality of life outcomes ·doi:10.1186/1477-7525-8-138

BACKGROUND: When comparing active treatments, a non-inferiority (or one-sided equivalence) study design is often used. This design requires the definition of a non-inferiority margin, the threshold value of clinical relevance. In recent stu…

article 2009
O341 Minimally clinically important difference for endometriosis associated pelvic pain measured on a visual analogue scale
·doi:10.1016/s0020-7292(09)60713-x
article 2008
Efficacy of a combined oral contraceptive containing 0.030 mg ethinylestradiol/2 mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035 mg ethinylestradiol/2 mg cyproterone acetate
·doi:10.1016/j.contraception.2008.10.010